Cargando…
Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten’s to the Letter to the editor Re: results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
Autores principales: | Wiegel, Thomas, Albers, Peter, Bartkowiak, Detlef, Bussar-Maatz, Roswitha, Härter, Martin, Kristiansen, Glen, Martus, Peter, Wellek, Stefan, Schmidberger, Heinz, Grozinger, Klaus, Renner, Peter, Schneider, Fried, Burmester, Martin, Stöckle, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954727/ https://www.ncbi.nlm.nih.gov/pubmed/33625578 http://dx.doi.org/10.1007/s00432-021-03549-y |
Ejemplares similares
-
Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
por: Albers, Peter, et al.
Publicado: (2020) -
Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)
por: Wiegel, Thomas, et al.
Publicado: (2020) -
Henkel reports robust 1Q 2020 sales performance
Publicado: (2020) -
Zimmermann Asociados
Publicado: (1993) -
El telegrama Zimmermann /
por: Tuchman, Barbara W. (Barbara Wertheim), 1912-1989
Publicado: (1960)